EricSamuelNadlerMD

PubMed

• Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
  Xiuning Le, Eric Nadler, Daniel B Costa, John Victor Heymach> ;Targeted Oncology. 2024 Jan 1
• Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
  Xiuning Le, Eric Nadler, Daniel B Costa, John Victor Heymach> ;Targeted Oncology. 2023 Nov 1
• 1 citations
  EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.
  Xiuning Le, Eric Nadler, Daniel B Costa, John Victor Heymach> ;Targeted Oncology. 2023 Nov 1
• Real-world relationship of early end points to survival end points in patients with resectable non-small-cell lung cancer.
  Eric Nadler, Anupama Vasudevan, Chuck Wentworth, Nicholas Robert, John R Penrod, Joseph Fiore, Lien Vo> ;Future Oncology. 2023 Aug 1
• Real-world study of patients with locally advanced HNSCC in the community oncology setting.
  Christopher M Black, Karthik Ramakrishnan, Eric Nadler, Wan-Yu Tseng, Chuck Wentworth, John Murphy, Nicole Fulcher, Liya Wang, Melannie Alexander, Gregory Patton> ;Frontiers in Oncology. 2023 Jan 1
• 4 citations
  Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology network.
  Shibani Pokras, Wan-Yu Tseng, Janet L Espirito, April Beeks, Ken Culver, Eric Nadler> ;Future Oncology. 2022 Oct 1
• 12 citations
  Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.
  Matthew H. Taylor, Courtney Betts, Lauren Maloney, Eric Nadler, Alain Algazi, Michael J. Guarino, John Nemunaitis, Antonio Jimeno, Priti Patel, Veerendra Munugalavadla...> ;Clinical Cancer Research. 2021 Dec 3
• 28 citations
  Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a r...
  Eric Nadler, Bhakti Arondekar, Kathleen M. Aguilar, Jie Zhou, Jane Chang, Xinke Zhang, Vivek Pawar> ;Journal of Cancer Research and Clinical Oncology. 2021 Mar 1
• 8 citations
  Real-world disease burden and outcomes of brain metastases in EGFR mutation-positive non-small-cell lung cancer.
  Eric Nadler, Janet L. Espirito, Melissa Pavilack, Bismark Baidoo, Ancilla W. Fernandes> ;Future Oncology. 2020 Jun 4
• 2 citations
  Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices.
  Eric Nadler, Kathleen M. Aguilar, Chuck Wentworth, Marley Boyd, E. Susan Amirian, Scott S. Barker, Pearl Plernjit French, Thomas Wilson, Lisa M. Hess> ;Sarcoma. 2020 Feb 28
• 15 citations
  Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-T...
  Eric Nadler, Melissa Pavilack, Janet L. Espirito, Jamyia Clark, Ancilla W. Fernandes> ;Advances in Therapy. 2020 Jan 18
• 11 citations
  Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neck
  Eric Nadler, S. Joo, Marley Boyd, Jenny Black-Shinn, Diana Chirovsky> ;Future Oncology. 2019 Mar 1
• 9 citations
  Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database Analysis.
  Kathleen M. Aguilar, Katherine B. Winfree, Catherine Muehlenbein, Yajun Emily Zhu, Thomas Wilson, Stewart Wetmore, Eric Nadler> ;Advances in Therapy. 2018 Oct 19
• 28 citations
  Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting.
  Eric Nadler, Janet L. Espirito, Melissa Pavilack, Marley Boyd, Andrea Leninka Vergara-Silva, Ancilla W. Fernandes> ;Clinical Lung Cancer. 2018 Jul 1
• 8 citations
  Clinical Pathways and the Patient Perspective in the Pursuit of Value-Based Oncology Care
  Jennifer L. Ersek, Eric Nadler, Janet Freeman-Daily, Samir Mazharuddin, Edward S. Kim> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2017 Jan 1
• 17 citations
  Epidemiology, treatment patterns, and outcomes of metastatic soft tissue sarcoma in a community-based oncology network.
  Clara Chen, Rohit Borker, James I. Ewing, Wan-Yu Tseng, Michelle D. Hackshaw, Shanmugapriya Saravanan, Rahul Dhanda, Eric Nadler> ;Sarcoma. 2014 Jan 12
• 18 citations
  Treatment patterns and outcomes in patients with non-squamous advanced non-small cell lung cancer receiving second-line treatment in a community-based oncology network.
  I-Wen Pan, Rajiv Mallick, Rahul Dhanda, Eric Nadler> ;Lung Cancer. 2013 Dec 1
• 13 citations
  Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents.
  Pei-Jung Lin, Thomas W Concannon, Dan Greenberg, Joshua T. Cohen, Gregory Rossi, Jeffrey Hille, Hannah R. Auerbach, C Fang, Eric Nadler, Peter J. Neumann> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2013 Aug 1
• 24 citations
  In A Survey, Marked Inconsistency In How Oncologists Judged Value Of High-Cost Cancer Drugs In Relation To Gains In Survival
  Peter A. Ubel, Scott R. Berry, Eric Nadler, Chaim M. Bell, Michael A. Kozminski, Jennifer A. Palmer, William K. Evans, Elizabeth Laureen Strevel, Peter J. Neumann> ;Health Affairs. 2012 Apr 1
• 13 citations
  Costs and Clinical Outcomes among Patients with Second-Line Non-small Cell Lung Cancer in the Outpatient Community Setting
  Eric Nadler, Michael Forsyth, Sacha Satram-Hoang, Carolina Reyes> ;Journal of Thoracic Oncology. 2012 Jan 1
• 18 citations
  How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments.
  Michael A. Kozminski, Peter J. Neumann, Eric Nadler, Aleksandra Jankovic, Peter A. Ubel> ;Medical Decision Making. 2011 May 1
• 221 citations
  Measuring patient-centered communication in cancer care: a literature review and the development of a systematic approach.
  Lauren McCormack, Katherine Treiman, Douglas Rupert, Pamela Williams-Piehota, Eric Nadler, Neeraj Arora, William F. Lawrence, Richard L. Street> ;Social Science & Medicine. 2011 Apr 1
• 24 citations
  Bevacizumab Treatment to Progression After Chemotherapy: Outcomes from a U.S. Community Practice Network
  Eric Nadler, Elaine W. Yu, Arliene Ravelo, Amy P. Sing, Michael Forsyth, Stephen K. Gruschkus> ;The Oncologist. 2011 Apr 1
• 58 citations
  Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs
  Scott R. Berry, Chaim M. Bell, Peter A. Ubel, William K. Evans, Eric Nadler, Elizabeth Laureen Strevel, Peter J. Neumann> ;Journal of Clinical Oncology. 2010 Sep 20
• 103 citations
  Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists
  Peter J. Neumann, Jennifer A. Palmer, Eric Nadler, C Fang, Peter A. Ubel> ;Health Affairs. 2010 Jan 1
• Join now to see all